• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Specific viruses may be associated with increased risk and worse outcomes of ovarian cancer

byDonika YakoubandAlex Chan
December 8, 2023
in Infectious Disease, Obstetrics, Oncology
Reading Time: 2 mins read
Quick Take: Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma
Share on FacebookShare on Twitter

1. This retrospective cohort study tested ovarian tumors for 113 viruses and found six viruses of interest (VOIs) that were present in one-quarter of tumors.

2. The presence of one of these VOIs was associated with a four-fold decrease in overall survival (OS) compared to those with any other viral strain or no viral strains. This finding did not apply to women above the age of 70, however.

Evidence Rating Level: 2 (Good)

Infectious agents are thought to cause just shy of one-fifth of cancer cases globally, and thus far, ovarian cancer is not known to have an infectious etiology. Internationally, eleven infectious organisms are currently classified as carcinogenic. However, one such infectious agent, human papillomavirus (HPV), is often found in ovarian tumors. The literature has not elucidated whether this takes place after the development of cancer or prior to it, but there is data to suggest that the expression of viral microRNA in tumors could be associated with worse clinical outcomes. Thus, this current study sought to assess whether ovarian tumors commonly carried viruses and whether presence of viruses in ovarian tumors was associated with decreased overall survival (OS). Tumor cells were analyzed from 98 patients (archived tumors) and any tissue that had been exposed to chemotherapies were excluded. The samples were tested by polymerase chain reaction (PCR) to detect 113 infectious agents. Results indicated that 46.9% of all samples contained at least one virus, and the most common viruses identified included herpesviruses EBV1 and HHV6b, polyomavirus MCPyV, a gamma HPV type (HPV4), a beta HPV types (HPV23), and one mucosal high-risk HPV (HPV16). In high-grade serous epithelial cancer, the most common histology of ovarian cancer, one or more of these six viruses of interest (VOI) were present in one quarter of tumors. Overall, patients with tumors containing any of these VOIs had a four-fold worse OS than those with other infectious agents or no virus present (HR 4.11, p = .0001; median survival 22 versus 44 months). This difference was no longer significant in women over the age of 70 (p > .05). Other factors also associated with lower OS included older age and advanced stage at diagnosis. Overall, these results indicate that viral infiltration of ovarian tumors may have implications for survival, but future studies should elucidate whether or not there is an element of reverse causation between these viruses and cancers.

Click to read the study in PLOSONE

Image: PD

RELATED REPORTS

A health coaching intervention may improve blood pressure control in postpartum women

Surgery is associated with an increased quality of life in women with endometriosis

Intraarterial dexamethasone may be effective for pain relief following uterine fibroid embolization

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: gynecologyinfectious disesaeobstetricsovarian cancervirology
Previous Post

Low-dose amitriptyline effective and well-tolerated for management of irritable bowel syndrome

Next Post

2 Minute Medicine Rewind December 11, 2023

RelatedReports

Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

A health coaching intervention may improve blood pressure control in postpartum women

August 12, 2026
Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Chronic Disease

Surgery is associated with an increased quality of life in women with endometriosis

August 11, 2026
Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding
Chronic Disease

Intraarterial dexamethasone may be effective for pain relief following uterine fibroid embolization

August 5, 2026
Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding
Weekly Rewinds

2 Minute Medicine Rewind August 3rd, 2026

August 3, 2026
Next Post
Quick Take: Association of Visual Impairment With Economic Development Among Chinese Schoolchildren

2 Minute Medicine Rewind December 11, 2023

Eating in the absence of hunger linked to toddler obesity

Dietary factors early in life may influence the development of celiac disease

Patient Basics: Lung Cancer Overview

Tiragolumab With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage SCLC

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • First messenger RNA influenza vaccine outperforms standard-dose vaccination
  • Few interventions improve posthospitalization follow-up for alcohol use disorder
  • Borderline-low hemoglobin levels linked to increased mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.